ML401

CAS No. 1597489-14-9

ML401( —— )

Catalog No. M22038 CAS No. 1597489-14-9

ML401 is a selectively EBI2(GPR183) receptor antagonist(IC50 of 1.03 nM) .

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 174 Get Quote
5MG 260 Get Quote
10MG 410 Get Quote
25MG 678 Get Quote
50MG 954 Get Quote
100MG 1287 Get Quote
500MG 2574 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    ML401
  • Note
    Research use only, not for human use.
  • Brief Description
    ML401 is a selectively EBI2(GPR183) receptor antagonist(IC50 of 1.03 nM) .
  • Description
    ML401 is a selectively EBI2(GPR183) receptor antagonist(IC50 of 1.03 nM) .
  • In Vitro
    ML401 shows no toxicity (>50 μM) towards immortalized Fa2-N4 human hepatocytes and non-cytotoxic in MTT in both LnCap and IMR-32 cells (>50 μM).
  • In Vivo
    ML401 shows very good stability in both human plasma and mouse plasma.
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    GPR
  • Recptor
    GPR183
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1597489-14-9
  • Formula Weight
    419.74
  • Molecular Formula
    C20H20BrClN2O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mg/mL (23.82 mM; Need ultrasonic)
  • SMILES
    C1CN(CCN1CC2=CC=C(C=C2)Cl)C(=O)C=CC3=CC=C(C=C3)Br
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ardecky R, et al. Functional Antagonists of EBI-2. Probe Reports from the NIH Molecular Libraries Program [Internet].
molnova catalog
related products
  • Azathioprine

    Azathioprine is an immunosuppressive drug, inhibiting purine synthesis and GTP-binding protein Rac1 activation, used in the treatment of organ transplantation and autoimmune diseases.

  • SC75741

    SC75741 is a potent NF-κB inhibitor with EC50 of 200 nM.

  • GLPG1205

    GLPG1205 is a potent, orally active GPR84 (G protein-coupled receptor) antagonist with anti-inflammatory activity. GLPG1205 shows good PK/PD characteristics and can be used to study pulmonary fibrosis.